City

Nashville (2)

Los Angeles (1)

Condition

Chronic Orthostatic Intolerance (3)

Postural Orthostatic Tachycardia Syndrome (1)

Postural Tachycardia Syndrome (1)

Syncope (1)

Tachycardia (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Satish R. Raj (2)

Cedars-Sinai Medical Center (1)

Collaborator

National Center for Research Resources (NCRR) (1)

National Institutes of Health (NIH) (1)

Study Documents

Intervention Type

drug (2)

procedure (2)

device (1)

dietary supplement (1)

other (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

chronic orthostatic intolerance

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Postural Orthostatic Tachycardia Syndrome, Chronic Orthostatic Intolerance, Syncope Trial in Los Angeles (Mirabegron 50 MG,

Not yet recruiting

Postural Orthostatic Tachycardia Syndrome
+2 more

Mirabegron 50 MG
Mirabegron 25 MG

Los Angeles, California

Cedars-Sinai Medical Center

Nov 14, 2023

Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)

Active, not recruiting

Tachycardia
Chronic Orthostatic Intolerance

Acetazolamide
+22 more

Nashville, Tennessee

Vanderbilt University Autonomic Dysfunction Center

Sep 12, 2022

Objective Sleep Disturbances in Orthostatic Intolerance

Completed

Postural Tachycardia Syndrome
Chronic Orthostatic Intolerance

Polysomnography

Nashville, Tennessee

Vanderbilt Unviersity

Aug 9, 2018